Knowledge, attitude and practices about pharmacovigilance and adverse drug reactions among dental research assistants in a Turkish hospital: a cross-sectional study
Öz
Objective: This study was aimed to assess pharmacovigilance and adverse drug reactions knowledge, attitudes and practices of dental research assistants.
Material and Method: A cross-sectional survey was conducted in a teaching hospital at Cukurova University, Adana, Turkey, for one month. All the registered dental research assistants were invited to participate in the study. Data collection was carried out through the self-administered and validated questionnaire. The final data was analyzed by using SPSS version 21.0 (IBM, Armonk, NY, USA). Descriptive statistics such as frequencies and percentages have been determined.
Results: The questionnaire was completed by invited participants with a response rate of 92.5%. Male (n=30, 60%) was more than female (n=20, 40%) with an average age of 27.44 (SD± 2.32) years. None of the participants received pharmacovigilance training in the last 1 year. The majority of participants (60%) were unable to define pharmacovigilance and only 20% (n=10) of the dentists have correctly defined ADRs. The Most of respondents (90%) recognize ADR reporting as a professional obligation and sixty percent (n=30) perceived that the reporting of serious and unexpected ADRs are mandatory. The participants perceived that difficulties during filling of ADR forms, loss of timing and lack of information on pharmacovigilance are the main reason for the under-reporting of ADRs. Moreover, all dentists reported that they did not observe serious/severe ADRs, and 40% (n=20) reported not asking about ADR history while interacting with a patient for the first time during their practice.
Conclusion: The current study demonstrated a lack of awareness and knowledge of pharmacovigilance and ADR among dental research assistants. The inclusion of pharmacovigilance literature in the education program is mandatory and pre-and post-graduate training should be provided to dentists for rational practices.
Anahtar Kelimeler
Destekleyen Kurum
None.
Proje Numarası
Not applicable
Kaynakça
- International society of pharmacovigilance. 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018. Drug Safety 2018; 41: 1103-273.
- Özcan G, Aykaç E, Kasap Y, Nemutlu NT, Sen E, Aydınkarahaliloğlu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs-real world outcomes 2016; 3: 33-43.
- Ithnin M, Rani MDM, Latif ZA, et al. Mobile app design, development and publication for adverse drug reaction assessments of causality, severity and preventability. JMIR Mhealth Uhealth 2017; 5: e78.
- Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess 2019; 8: 13-20.
- Alshakka M, Bahattab OA, Ali H, et al. Comparison of the knowledge and perception of pharmacovigilance among pharmacy, dental and medical students in Aden-Yemen. J Pharm Pract Community Med 2017; 3: 254-61.
- Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspect Clin Res 2015; 6: 144-9.
- Sivadasan S, Sellappan M. A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in a private university, Malaysia. Int J Current Pharm Res 2015; 7: 84-9.
- Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Trop J Pharm Res 2015; 14: 1899-905.
- Khan MU, Ahmad A, Ejaz A, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof 2015; 12: 28.
- Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136‑47.
- Mersha AG. Attitude and perception of medical interns about antimicrobial resistance: a multi-center cross-sectional study in Ethiopia. Antimicrob Resist Infect Control 2018; 7: 149.
- Yip J, Radford DR, Brown D. How do UK dentists deal with adverse drug reaction reporting? Br Dent J 2013; 214: e22.
- Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a private university, Malaysia. J Young Pharm 2015; 7: 118-25.
- Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health 2019; 11: 177-84. doi:10.1093/inthealth/ihy073.
- Karataş Y, Pelit A. Yeni çıkan ilaçların güvenlik (farmakovijilans) açısından izlenmesinin önemi [Translate: Importance of monitoring new drugs in terms of security (pharmacovigilance)]. Arşiv Kaynak Tarama Derg 2018; 27: 500-6.
- Sharma S, Khanal T, Shrestha S, Adhikari B. A celebration of world pharmacist day 2018 focusing to strengthen the pharmacy services at an oncology-based hospital in Nepal: Inspiration for others in developing countries. Res Social Adm Pharm 2019; 15: 117–8.
Öz
Proje Numarası
Not applicable
Kaynakça
- International society of pharmacovigilance. 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018. Drug Safety 2018; 41: 1103-273.
- Özcan G, Aykaç E, Kasap Y, Nemutlu NT, Sen E, Aydınkarahaliloğlu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs-real world outcomes 2016; 3: 33-43.
- Ithnin M, Rani MDM, Latif ZA, et al. Mobile app design, development and publication for adverse drug reaction assessments of causality, severity and preventability. JMIR Mhealth Uhealth 2017; 5: e78.
- Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess 2019; 8: 13-20.
- Alshakka M, Bahattab OA, Ali H, et al. Comparison of the knowledge and perception of pharmacovigilance among pharmacy, dental and medical students in Aden-Yemen. J Pharm Pract Community Med 2017; 3: 254-61.
- Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspect Clin Res 2015; 6: 144-9.
- Sivadasan S, Sellappan M. A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in a private university, Malaysia. Int J Current Pharm Res 2015; 7: 84-9.
- Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Trop J Pharm Res 2015; 14: 1899-905.
- Khan MU, Ahmad A, Ejaz A, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof 2015; 12: 28.
- Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136‑47.
- Mersha AG. Attitude and perception of medical interns about antimicrobial resistance: a multi-center cross-sectional study in Ethiopia. Antimicrob Resist Infect Control 2018; 7: 149.
- Yip J, Radford DR, Brown D. How do UK dentists deal with adverse drug reaction reporting? Br Dent J 2013; 214: e22.
- Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a private university, Malaysia. J Young Pharm 2015; 7: 118-25.
- Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health 2019; 11: 177-84. doi:10.1093/inthealth/ihy073.
- Karataş Y, Pelit A. Yeni çıkan ilaçların güvenlik (farmakovijilans) açısından izlenmesinin önemi [Translate: Importance of monitoring new drugs in terms of security (pharmacovigilance)]. Arşiv Kaynak Tarama Derg 2018; 27: 500-6.
- Sharma S, Khanal T, Shrestha S, Adhikari B. A celebration of world pharmacist day 2018 focusing to strengthen the pharmacy services at an oncology-based hospital in Nepal: Inspiration for others in developing countries. Res Social Adm Pharm 2019; 15: 117–8.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Orijinal Makale |
| Yazarlar | |
| Proje Numarası | Not applicable |
| Yayımlanma Tarihi | 22 Ekim 2020 |
| Yayımlandığı Sayı | Yıl 2020 Cilt: 3 Sayı: 4 |
Kaynak Göster
Cited By
Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]
Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.
Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.
Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show
Dergi Dizin ve Platformları
Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.
Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.